Filter This View

  • October 20, 2011 | New Jersey Law Journal

    Largest N.J. Mergers & Acquisitions

    table cols="5" xmlns:saxon="http://saxon.sf.net/" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:k4="http://www.vjoon.com/K4Export/1.4.2" xmlns:ma

    1 minute read

  • April 27, 2012 | The American Lawyer

    Cleary, Cooley, White & Case Grab Roles in Big Week for Pharma, Health Care Deals

    Several Am Law 100 and international firms shook off a first quarter M&A malaise by working on pharmaceutical and health care sector deals worth more than $25.6 billion all to

    1 minute read

  • Mutual Pharmaceutical Company, Inc. v. Bartlett

    Publication Date: 2013-06-24
    Practice Area:
    Industry:
    Date Filed: 2013-06-24
    Court: U.S. Sup. Ct.
    Judge:
    Attorneys: For plaintiff:
    for defendant:
    Case Number: No. 12-142

    Cite as 13 C.D.O.S. 6469 MUTUAL PHARMACEUTICAL COMPANY, INC., Petitioner v. KAREN L. BA

  • Clayworth v. Pfizer, Inc.

    Publication Date: 2010-07-12
    Practice Area:
    Industry:
    Date Filed: 2010-07-12
    Court: Ca. Sup. Ct.
    Judge:
    Attorneys: For plaintiff: Attorneys for Appellant: Alioto Law Firm, Joseph M. Alioto, Joseph M. Alioto, Jr., Theresa D. Moore, Angelina Alioto-Grace, Thomas P. Pier; Law Offices of John H. Boone, John H. Boone; Foreman & Brasso, Russell F. Brasso; Law Offices of James M. Dombroski, James M. Dombroski; Law Offices of Jeffery K. Perkins, Jeffrey K. Perkins; Gary D. McCallister & Associates, Gary D. McCallister, Thomas A. Kelliher, Eric I. Unrein and Jaime Goldstein for Plaintiffs and Appellants. Coughlin Stoia Geller Rudman & Robbins, Pamela M. Parker; Schubert Jonckheer Kolbe & Kralowec and Kimberly A. Kralowec for Consumer Attorneys of California as Amicus Curiae on behalf of Plaintiffs and Appellants. Zelle Hofmann Voelbel & Mason, Craig C. Corbitt and Henry A. Cirillo for Pharmacists Planning Services, Inc., as Amicus Curiae on behalf of Plaintiffs and Appellants.
    for defendant: Attorneys for Respondent: Filice Brown Eassa & McLeod, Peter A. Strotz, Paul R. Johnson, William E. Steimle; Davis Polk & Wardwell, Ameila Starr, Arthur F. Golden, William J. Fenrich and Daniel J. Schwartz for Defendant and Respondent AstraZeneca LP. Winston & Strawn, Tyler M. Paetkau, Nicole P. Dogwill, James F. Hurst, Susan A. Pipal, Matthew J. Sullivan; Eimer Stahl Klevorn & Solberg, David M. Stahl, J. Cunyon Gordon and Adam Oyenbanji for Defendant and Respondent Abbott Laboratories. Gibson, Dunn & Crutcher, Jeffrey T. Thomas and James N. Knight for Defendant and Respondent Allergan, Inc. Mayer, Brown, Rowe & Maw, Mayer Brown, Donald M. Falk, John Nadolenco, Mack Anderson; Sheppard Mullin Richter & Hampton, Steven O. Kramer, John P. Stigi III; Hogan & Hartson and Joseph H. Young for Defendant and Respondent Amgen, Inc. Covington & Burling, Elizabeth Abigail Brown, Anita F. Stork, Theodore Voorhees, Jr., and Thomas J. Cosgrove for Defendant and Respondent Boehringer Ingelheim Pharmaceuticals, Inc. Sedgwick, Detert, Moran & Arnold, Paul J. Riehle, Matthew A. Fischer; Cravath, Swaine & Moore, Evan R. Chesler, Elizabeth L. Grayer, Jessica Buturla and Jeffrey B. Korn for Defendant and Respondent Bristol-Myers Squibb Company. Reed Smith, Michael Diane Floyd, Kirsten J. Handelman; Oppenheimer Wolff & Donnelly, Gary Hansen, David Graham and Aaron Mills Scott for Defendant and Respondent Eli Lilly & Company. Irell & Manella, Alexander F. Wiles, John C. Keith; Cleary Gottlieb Steen & Hamilton, George S. Cary, Sara D. Schotland and David I. Gelfand for Defendant and Respondent GlaxoSmithKline PLC. Drinker Biddle & Reath, H. Christian L?Orange, Paul H. Saint-Antoine, Mary E. Kohart, David J. Antczak and Joanne C. Lewers for Defendant and Respondent Hoffmann-La Roche Inc. Folger Levin & Kahn, Crowell & Moring, Beatrice Bich-Dao Nguyen, Samuel Ray Miller, Tracy E. Reichmuth, Cecilia C. Ogbu, Steven E. Wilson; Patterson Belknap Webb & Tyler, William Cavanaugh, Jr., and Cecilia B. Loving for Defendants and Respondents Janssen Pharmaceutica Inc., Johnson & Johnson Health Care Systems, Inc., Ortho Biotech, Inc., and Ortho-McNeil Pharmaceutical, Inc. Hughes Hubbard & Reed, Rita M. Haeusler, John M. Townsend, Scott H. Christensen, James A. Graffam; Orrick, Herrington & Sutcliffe, Robert P. Reznick and David Goldstein for Defendant and Respondent Merck Sharp & Dohme Corp. formerly known as Merck & Co., Inc. Kaye Scholer, Aton Arbisser, Bryant S. Delgadillo, Saul P. Morgenstern, Karin E. Garvey; Faegre & Benson, James A. O?Neal and Kim J. Walker for Defendant and Respondent Novartis Pharmaceuticals Corporation. Nossaman, Gunther, Knox & Elliott, Nossaman, Scott DeVries, Katrina June Lee; Dickstein Shapiro, Peter J. Kadzik, Bernard Nash, Maria Colsey Heard, Milton Marquis and Andres Colin for Defendant and Respondent Pfizer Inc. Latham & Watkins, Charles H. Samel, Jennifer A. Carmassi, Margaret M. Zwisler, Steven H. Schulman and Belinda S. Lee for Defendant and Respondent Pharmaceutical Research and Manufacturers of America. Arnold & Porter, Ronald C. Redcay, Douglas L. Wald, Mark R. Merley, Daniel R. Waldman, Anne P. Davis and Ryan Z. Watts for Defendant and Respondent Wyeth.
    Case Number: No. S166435

    Cite as 10 C.D.O.S. 87895JAMES CLAYWORTH et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Def

  • August 4, 2010 | The Legal Intelligencer

    Superior Court Recognizes New Pharma Cause of Action

    In a pharmaceutical liability case of first impression, the state Superior Court has ruled that plaintiffs can sue pharmaceutical companies for negligence in the design of their produc

    1 minute read

  • Pharmaceutical Research and Manufacturers of America v. Thompson

    Publication Date: 2001-06-12
    Practice Area:
    Industry:
    Date Filed: 2001-06-08
    Court: DC Cir.
    Judge: Tatel, Circuit Judge
    Attorneys: For plaintiff:
    for defendant:
    Case Number: 01-5029

    Argued April 10, 2001The Medicaid statute requires pharmaceutical manufacturers to rebate a portion of the price of their drugs as a condition for participating in Medicaid. In this case, pharmaceu

  • December 5, 2005 | New Jersey Law Journal

    Drug Ads: Has the Picture Changed?

    In Perez v. Wyeth Laboratories, Inc., 161 N.J. 1 (1999), the New Jersey Supreme Court held that a cause of action could exist against a pharmaceutical manufacturer for failure to warn c

    1 minute read

  • King Pharmaceuticals Inc. v. Eon Labs Inc., 04-cv-5540

    Publication Date: 2009-01-27
    Practice Area:
    Industry:
    Date Filed: 2009-01-20
    Court: U.S. District Court for the Eastern District
    Judge: David Trager
    Attorneys: For plaintiff:
    for defendant:
    Case Number: 04-cv-5540

    District Judge David G. Trager U.S. DISTRICT COURT EASTERN DISTRICT OF NEW YORK Judge Trager MEMORANDUM AND ORDER Plaintiffs King Pharmaceutical

  • December 13, 2006 | New Jersey Law Journal

    Lawyers' Fund for Client Protection - Lists

    Lawyers' Fund for Client Protection � Lists of Ineligible Foreign Legal Consult Ineligible In-House Counsel and Ineligible Pro Hac Vice AttorneysForeign legal consult

    1 minute read

  • December 3, 2010 | The American Lawyer

    Cleary Latest U.S. Firm to Launch Hong Kong Law Practice

    Cleary Gottlieb Steen & Hamilton on Thursday announced plans to launch a Hong Kong law practice with a partner recruited from U.K. firm Norton Rose. a href="http://www.nortonrose.com/pe

    1 minute read